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Background: Colon cancer stem cells are shown to be the self-renewing cells within a tumor that give rise to all
lineages of more differentiated tumor cells. In this respect they are remarkably similar to their non-malignant
counterparts that orchestrate the intestinal lining. This suggests that, despite the numerous genetic aberrations and
morphological changes that have occurred during cancer initiation and progression, a remnant homeostatic
regulation persists.
Findings: Using a number of human and mouse intestinal-derived organoid cultures from normal, adenoma and
cancerous tissues, we show here that Notch signals coordinate self-renewal and lineage determination not only in
normal, but also at the adenoma and carcinoma stage in both mice and humans. Moreover, the Wnt pathway,
which carries activating mutations in virtually all colon cancers, is not as previously predicted constitutively active in
adenomas and carcinomas, but still displays a heterogeneous activity pattern that determined stemness in all
stages of disease.
Conclusion: These data for the first time provide a comprehensive overview of Wnt and Notch-mediated signaling
in the different stages of the adenoma-carcinoma sequence and demonstrates that these morphogenic pathways,
despite mutations, remain crucial determinants of both architecture and hierarchy in normal and malignant
intestinal tissue.
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Normal gut homeostasis is ensured by intestinal stem
cells (ISCs), which rely on integration of various mor-
phogenic pathways including bone morphogenetic pro-
tein, Hedgehog, Notch and Wnt signaling cascades [1].
Colorectal cancer (CRC) is a multistep process in which
genetic hits induce transition from normal mucosa via
adenomatous lesions to an invasive carcinoma [2]. Ad-
enoma initiation is suggested to occur via deregulation* Correspondence: j.p.medema@amc.nl
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distribution, and reproduction in any mediumof these morphogenic pathways. First and foremost, mu-
tations leading to activation of the Wnt cascade are seen
in all CRC patients [1,3]. However, these activating mu-
tations never result in a complete activation, but rather
in a finely-tuned Wnt activity level [4]. Furthermore,
cell-to-cell variation in pathways activity is frequently
observed. In agreement with these concepts are our re-
cent observations that have pinpointed Wnt pathway
regulation as the basis of cancer stemness in CRC [5].
Functionally marked by high Wnt pathway activity,
colon cancer stem cells (CSCs) have self-renewal cap-
acity and the potential to differentiate into all cell line-
ages present in cancerous tissue [6]. These similarities
between ISCs and CSCs may therefore point to thetral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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http://www.molecular-cancer.com/content/12/1/126intriguing possibility that the response to morphogenic
signals is not lost during tumorigenesis. Despite the
wealth of data regarding the role of morphogenic path-
ways in controlling cell fate and proliferation in intes-
tinal tissue, to our surprise few studies have attempted
to comprehensively assess their role throughout the
stages of neoplastic progression. For example, whereasA
B
C
Figure 1 Multi-lineage potential of intestinal cultures from multiple s
and immunohistochemistry images displaying epithelial cells (EpCAM), gob
healthy epithelial derived from small intestine (mouse) and colon (human),Notch inhibition leads to goblet cells accumulation in
adenomas [7], little is known on the role of Wnt signal-
ing in this stage.
Using a number of human and mouse intestinal-derived
organoid cultures from normal, adenoma and cancerous
tissues [8,9], we provide a comprehensive overview on the
role of both Wnt and Notch morphogenic pathways in thetages of CRC development. A representative overview of confocal
let cells (MUC2) and enterocytes (Villin) in organoid cultures of (A)
(B) adenoma (C) adenocarcinoma (human). Scale bar: 50 μm.
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http://www.molecular-cancer.com/content/12/1/126different stages of CRC development. We find that
Notch inhibition decreases stemness and enhances
goblet-like differentiation in all stages of disease. Con-
versely, Wnt activity is associated with stemness in nor-
mal, adenoma and carcinoma tissue. Our results point
to the conclusion that colon carcinogenesis, at early andA
B
D
Figure 2 The Notch pathway is analogously orchestrated throughout
MUC2 (green) in human cultures treated with 10 μM dibenzazepine (DBZ)
increased MUC2 expression (B) The number of goblet cells was quantified
magnification. Values shown are the percentages of MUC2+ cells relative to
further measured with qRT-PCR. MUC2 mRNA levels were normalized to GA
control. The graph represents the mean ± SD of three different experimen
depicted are representative from three independent experiments from hum
adenocarcinoma (N=3). Scale bar: 50 μm. * p<0.05, ** p<0.01, ***p<0.001, *late stages consistently retain numerous characteristics
of the normal intestine.
Findings
Normal intestinal epithelial cultures rapidly self-
organized into typical single layered organoid structuresC
CRC progression. (A) Representative confocal microscopy images of
show differentiation into the goblet cell-lineage as depicted by
by counting the number of MUC2+ cells from 10 random fields at 63×
the total number of cells. (C) The increased MUC2 expression was
PDH mRNA and expressed as fold induction compared with DMSO
ts. (D) DBZ treatment results in reduced clonogenicity. The results
an healthy colon organoid (N=2), adenoma (N=3) and
***p<0.0001 (t-test).
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http://www.molecular-cancer.com/content/12/1/126composed of epithelial cells (EpCAM+) surrounding a
central lumen (Figure 1). As previously shown, organoids
contained the various differentiated gut cell types, includ-
ing neuroendocrine cells (Chromogranin A, (CHGA))
(Additional file 1: Figure S1A), goblet cells (MUC2) and
enterocytes (Villin) (Figure 1A) [8,9]. Adenoma cultures
contained scattered goblet-like cells judged by MUC2
staining (Figure 1B), but appeared to lack CHGA+ cells
(Additional file 1: Figure S1A) consistent with previous
observations [10] and stainings on the corresponding
primary tumor material (Additional file 1: Figure S1B). In-
triguingly, when analyzing CRC spheroid cultures, derived
from a single cell clone and reportedly enriched in CSCs
[11], we detected the presence of various lineagesA
B C
Figure 3 Functional Wnt activity is maintained throughout CRC devel
epithelial, mouse adenoma, and human adenocarcinoma sections show a
signaling hierarchy in vivo (upper panel). Images are taken at 20× magnific
derived from the corresponding tissues shows the heterogeneity of Wnt ac
at 63× magnification. (B) Representative graph of qRT-PCR analysis from TO
mRNA values of several Wnt target genes and stem cell markers were first
compared to TOP-GFPlow. (C and D) Colony-forming efficiency in the sorte
clonogenic potential in both mouse (C) and human (D) adenoma cultures
experiments from mouse adenoma cultures (N=2) and human adenoma cu(Figure 1C) including the CHGA+ neuroendocrine cell
lineage. This demonstrates that differentiation towards the
distinct epithelial lineages occurs even in late stage cancers
and, whenever present, this process might be similarly or-
chestrated at all stages of the disease.
To address this, we first assessed the effect of pharma-
cological inhibition of the Notch pathway in the distinct
cultures. As previously reported, dibenzazepine (DBZ)
mediated Notch inhibition resulted in goblet cell differ-
entiation in cultured mouse intestinal epithelium and
adenoma (Additional file 2: Figure S2). Importantly, also
treatment of human epithelial organoid cultures derived
either from normal, adenoma or adenocarcinoma tis-
sues with DBZ, caused a clear increase in goblet cellsD
opment. (A) Immunohistochemistry staining from mouse intestinal
heterogeneous β-catenin intracellular distribution indicating Wnt
ation. Lentiviral transduction of TOP-GFP reporter in the cultures
tivity in vitro (lower panel). The confocal microscopy images are taken
P-GFPhigh and TOP-GFPlow fractions of mouse adenoma cultures. The
normalized with GAPDH mRNA and expressed as fold induction
d TOP-GFP cells showing that TOP-GFPhigh cells exhibit higher
. Data shown represents mean ± SD from three independent
ltures (N=2). Scale bar, 50 μm. * p<0.05, ** p<0.01, ***p<0.0001 (t-test).
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http://www.molecular-cancer.com/content/12/1/126(Figure 2A-B) and a significant induction of MUC2
mRNA level (Figure 2C). This goblet cell-like differenti-
ation appeared to be observed only in cultures already
expressing low amounts of MUC2 (Additional file 3:
Figure S3). More importantly, the clonogenic potential
of all cultures was clearly decreased upon DBZ treat-
ment, which is consistent with the loss of (cancer) stem
cells (Figure 2D and Additional file 2: Figure S2), imply-
ing that Notch pathway-dependent self-renewal and cell
fate decision are maintained at all stages of tumor
development.
Secondly, we carefully assessed the Wnt pathway activity
in all derived cultures using the TCF/LEF reporter con-
struct (TOP-GFP) [5]. As mentioned above, deregulation
of the Wnt pathway is frequently observed in CRC devel-
opment and we have shown that high Wnt activity can be
used as a functional CSCs marker in adenocarcinomas [5].
In addition, recent reports have highlighted the heteroge-
neous expression of the Wnt target and stem cell marker
LGR5 in both adenomas and carcinomas [12,13]. As
expected, a hierarchy in Wnt pathway activity in healthy
epithelial and adenocarcinoma organoid cultures could be
detected by distinct GFP patterning (Figure 3A). Intri-
guingly, adenoma cultures also display heterogeneous
Wnt activity, with TOP-GFPhigh adenoma cells displaying
high levels of stem cell marker genes. More importantly,
TOP-GFPhigh adenoma cells represented the clonogenic
fraction. This indicates that the functional hierarchy of the
Wnt pathway, which is known for normal epithelium and
adenocarcinoma CSCs, also identifies stemness in aden-
omas (Figure 3C-D).
Discussion
Previous studies have highlighted the role of Wnt and/or
Notch in distinct stages of colon cancer. For instance,Figure 4 The signaling architecture defining self-renewal and lineage
genetic hits accumulate during progression (e.g. depicted as APC mutation
are orchestrated similarly between normal and cancerous tissues. On the le
gradient of Wnt signals (green, high (dark green) in normal stem cells and
The right part of each progression step depicts the response to a specific m
differentiation towards goblet cells (pink).Notch inhibition has been shown to induce goblet differ-
entiation in mouse adenomas and block stemness in colon
CSCs [7,14]. Similarly, we have previously shown that
Wnt activity determines stemness in adenocarcinoma-
derived colon CSCs. This present study, however, for the
first time provides a comprehensive overview of these
pathways at all stages and extends these surprising find-
ings by showing that Wnt pathway heterogeneity persists
at all stages despite evident mutations in the Wnt pathway
and that Notch signals maintain a balance between self-
renewal and cell lineage decisions. Currently, the mole-
cular mechanisms underlying such heterogeneity remain
unclear. Nevertheless, the organization appears to be
purely intrinsic to epithelial cells as the mesenchymal
niche is not present in vitro. Differential Wnt activity in
the normal epithelial organoid cultures was suggested to
exist due to the presence of Wnt/Notch ligand producing
paneth cells [15]. Likewise, tuning of Wnt signaling in ad-
enoma or adenocarcinoma might be achieved by a similar
mechanism. In this respect, it is interesting to note that
paneth-like cells have been reported in mouse adenomas
and reside in close proximity to the LGR5+ adenoma stem
cells [13]. Furthermore, microenvironment derived signals
such as HGF and Jagged-1 [5,16] could also be responsible
for this Wnt hierarchy.
Conclusion
Our data on a unique panel of cultures, representing
normal, pre-malignant neoplastic lesions as well as
adenocarcinoma tissue from both mouse and human
origin, shows that at all stages of disease, the tissue is
organized in a highly similar hierarchical fashion and
present with cell types encompassing multiple differenti-
ation lineages. Here we find that the Wnt and Notch
pathways are not only crucial for the orchestration ofspecification is maintained in colon cancer progression. Although
in adenoma), signals defining self-renewal and lineage specification
ft part of each progression step, stemness potential is defined by a
cancer stem cells and low (light green) in differentiated (tumor) cells).
orphogenic cue; in this case inhibition of Notch signaling promotes
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http://www.molecular-cancer.com/content/12/1/126this hierarchy but their function in regulating self-
renewal and cell fate is also conserved during cancer de-
velopment. Furthermore, our data provide evidence that
the robust mechanism orchestrating hierarchy in normal
intestinal epithelium is strongly wired in the epithelial
cells and its regulation is sustained throughout carcino-
genesis (Figure 4). The Wnt and Notch pathways, even
though subjected to mutation or aberrant regulation,
maintain their central position in the regulation of this
hierarchy. These parallels between normal and neoplas-
tic tissue notably makes targeted therapies towards these
pathways challenging, as it will predictably impact nor-
mal hierarchy. Understanding similarities, but above all
the differences in molecular mechanisms will help in
highlighting crucial differences that can be exploited for
therapeutic design.Materials and methods
Murine tissue culture
The Animal Experimental Committee (DEC) of the Aca-
demic Medical Center (AMC) approved all animal experi-
ments. Normal crypt (C57B7/6) and adenoma cultures
(Lgr5-EGFP-IRES-creERT2/APCflox/flox) mice cultures were
generated and maintained as previously described by [8]
and [17] respectively.Human tissue culture
Human tissues were obtained in accordance with the le-
gislation in the Netherlands and approved by the medical
ethical committee in the AMC. Human crypt, adenoma
and carcinoma cultures were generated and maintained as
previously described [9,18].Dibenzazepine treatment and clonogenicity assays
For clonogenic assays 150 crypts and 5000 adenoma calls
were plated per well in triplicate and outgrowth was mea-
sured after 3 days and 7 days respectively of 10 μM
dibenzazepine (DBZ) (Merck) treatment. For statistical
analysis two-tailed t-tests were applied. Clonogenicity for
adenocarcinomas was determined in a limiting dilution
fashion at 1, 2, 4, 8, 16, 32, 64 and 128 cells per well in a
ultra-low adherent 96 well plate (Corning) after 10 μM
DBZ treatment. Results were statistically evaluated
using the R software package (http://bioinf.wehi.edu.au/
software/elda/index.html).Lentiviral transduction
Organoid transductions, as in [19], were performed using
TCF/LEF reporter driving expression of GFP (TOP-GFP)
was a gift from Laurie Ailles. For clonogenicity assays,
5000 cells were sorted (FACSAria, BD) TOP-GFPhigh and
TOP-GFPlow.RT-qPCR analysis
Total RNA was extracted using the RNeasy kit (Qiagen)
and cDNA was synthesized using SuperScript® III re-
verse transcriptase (Life Technologies) with random
primers (Invitrogen) using 2xSYBR Green Master Mix
(Roche) for RT-qPCR measurement. For primers see
Additional file 4.
Immunohistochemistry and immunofluorescence
Immunohistochemistry stainings were analyzed in
formalin-fixed, paraffin-embedded tissues and analyzed
using standard techniques. 8-chamber culture slides
(BD) were used for whole mount immunofluorescent
stainings. Images were taken on a Leica TCS-SP2. For
antibodies see Additional file 4.
Additional files
Additional file 1: Figure S1. Marker expression of various cell lineages
during different stages of CRC development.
Additional file 2: Figure S2. Induction of goblet cells in mouse
organoid cultures upon DBZ treatment in normal mouse epithelial cells
and adenoma organoid cultures.
Additional file 3: Figure S3. Induction of goblet cells following DBZ
treatment correlates with basal MUC2 expression.
Additional file 4: Table S1. RT-qPCR primers. Table S2: Antibody list.
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